Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Front Immunol. 2019 Jul 24;10:1694. doi: 10.3389/fimmu.2019.01694. eCollection 2019.
Antibodies against foreign antigens are a critical component of the overall immune response and can facilitate pathogen clearance during a primary infection and also protect against subsequent infections. Dysregulation of the antibody response can lead to an autoimmune disease, malignancy, or enhanced infection. Since the experimental delineation of a distinct B cell lineage in 1965, various methods have been developed to understand antigen-specific B cell responses in the context of autoimmune diseases, primary immunodeficiencies, infection, and vaccination. In this review, we summarize the established techniques and discuss new and emerging technologies for probing the B cell response and by taking advantage of the specificity of B cell receptor (BCR)-associated and secreted antibodies. These include ELISPOT, flow cytometry, mass cytometry, and fluorescence microscopy to identify and/or isolate primary antigen-specific B cells. We also present our approach to identify rare antigen-specific B cells using magnetic enrichment followed by flow cytometry. Once these cells are isolated, proliferation assays and adoptive transfer experiments in mice can be used to further characterize antigen-specific B cell activation, function, and fate. Transgenic mouse models of B cells targeting model antigens and of B cell signaling have also significantly advanced our understanding of antigen-specific B cell responses .
针对外来抗原的抗体是整体免疫反应的关键组成部分,能够促进初次感染期间病原体的清除,并且还能预防随后的感染。抗体反应的失调可导致自身免疫性疾病、恶性肿瘤或增强的感染。自 1965 年明确区分出一个独特的 B 细胞谱系以来,已经开发了各种方法来了解自身免疫性疾病、原发性免疫缺陷、感染和疫苗接种背景下的抗原特异性 B 细胞反应。在这篇综述中,我们总结了已确立的技术,并讨论了用于探测 B 细胞反应的新技术和新兴技术,同时利用了 B 细胞受体 (BCR) 相关和分泌抗体的特异性。这些技术包括 ELISPOT、流式细胞术、质谱流式细胞术和荧光显微镜,以鉴定和/或分离原发性抗原特异性 B 细胞。我们还介绍了我们使用磁珠富集 followed by 流式细胞术来鉴定稀有抗原特异性 B 细胞的方法。一旦这些细胞被分离出来,可以进行增殖测定和在小鼠中的过继转移实验,以进一步表征抗原特异性 B 细胞的激活、功能和命运。针对模型抗原和 B 细胞信号的 B 细胞转基因小鼠模型也显著推进了我们对抗原特异性 B 细胞反应的理解。